Delivery of therapeutic nucleic acids via transferrin and transferrin receptors: lipoplexes and other carriers

Bibliography

• MacGillivray RT, Mendez E, Shewale JG, et al. The primary structure of human serum transferrin. The structures of seven cyanogen bromide fragments and the assembly of the complete structure. J Biol Chem 1983;258:3543-53
   PubMed Web of Science ®Google Scholar
• Klausner RD, Harford J, van Renswoude J. Rapid internalization of the transferrin receptor in K562 cells is triggered by ligand binding or treatment with a phorbol ester. Proc Natl Acad Sci USA 1984;81:3005-9
   PubMed Web of Science ®Google Scholar
• van Renswoude J, Bridges KR, Harford JB, et al. Receptor-mediated endocytosis of transferrin and the uptake of Fe in K562 cells: identification of a nonlysosomal acidic compartment. Proc Natl Acad Sci USA 1982;79:6186-90
   PubMed Web of Science ®Google Scholar
• Mayle KM, Le AM, Kamei DT. The intracellular trafficking pathway of transferrin. Biochim Biophys Acta 2012;1820:264-81
   PubMed Web of Science ®Google Scholar
• Klausner RD, Ashwell G, van Renswoude J, et al. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc Natl Acad Sci USA 1983;80:2263-6
   PubMed Web of Science ®Google Scholar
• Daniels TR, Bernabeu E, Rodríguez JA, et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta 2012;1820:291-317
   PubMed Web of Science ®Google Scholar
• Wagner E, Zenke M, Cotten M, et al. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci USA 1990;87:3410-14
   PubMed Web of Science ®Google Scholar
• Cotten M, Längle-Rouault F, Kirlappos H, et al. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc Natl Acad Sci USA 1990;87:4033-7
   PubMed Web of Science ®Google Scholar
• Cheng PW. Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum Gene Ther 1996;7:275-82
   PubMed Web of Science ®Google Scholar
• Xu L, Pirollo KF, Chang EH. Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Hum Gene Ther 1997;8:467-75
   PubMed Web of Science ®Google Scholar
• Simões S, Slepushkin V, Gaspar R, et al. Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther 1998;5:955-64
   PubMed Web of Science ®Google Scholar
• Simões S, Slepushkin V, Gaspar R, et al. Successful transfection of lymphocytes by ternary lipoplexes. Biosci Rep 1999;19:601-9
   PubMed Web of Science ®Google Scholar
• Simões S, Slepushkin V, Pretzer E, et al. Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides. J Leukoc Biol 1999;65:270-9
   PubMed Web of Science ®Google Scholar
• Simões S, Slepushkin V, Pires P, et al. Mechanisms of gene transfer mediated by lipoplexes associated with targeting ligands or pH-sensitive peptides. Gene Ther 1999;6:1798-807
   PubMed Web of Science ®Google Scholar
• Xu Y, Szoka FC Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996;35:5616-23
   PubMed Web of Science ®Google Scholar
• Singh M, Hawtrey A, Ariatti M. Lipoplexes with biotinylated transferrin accessories: novel, targeted, serum-tolerant gene carriers. Int J Pharm 2006;321:124-37
   PubMed Web of Science ®Google Scholar
• Nomura T, Nakajima S, Kawabata K, et al. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res 1997;57:2681-6
   PubMed Web of Science ®Google Scholar
• Blezinger P, Freimark BD, Matar M, et al. Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases. Hum Gene Ther 1999;10:723-31
   PubMed Web of Science ®Google Scholar
• Nabel GJ, Gordon D, Bishop DK, et al. Immune response in human melanoma after transfer of an allogenic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci USA 1996;93:15388-93
   PubMed Web of Science ®Google Scholar
• Voges J, Reszka R, Gossmann C, et al. Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann Neurol 2003;54:479-87
   PubMed Web of Science ®Google Scholar
• Li S, Yu B, An P, et al. Combined liposome-mediated cytosine deaminase gene therapy with radiation in killing rectal cancer cells and xenografts in athymic mice. Clin Cancer Res 2005;11:3574-8
   PubMed Web of Science ®Google Scholar
• Sher YP, Tzeng TF, Kan J, et al. Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival. Oncogene 2009;28:2123-30
   Web of Science ®Google Scholar
• Koldehoff M, Steckel NK, Beelen DW, et al. Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia. Clin Exp Med 2007;7:47-55
   PubMed Web of Science ®Google Scholar
• Okumura K, Nakase M, Inui M, et al. Bax mRNA therapy using cationic liposomes for human malignant melanoma. J Gene Med 2008;10:910-17
   PubMed Web of Science ®Google Scholar
• Goplan B, Ito I, Branch CD, et al. Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response. Tech Cancer Res Treat 2004;3:647-57
   PubMed Web of Science ®Google Scholar
• Rubin J, Galanis E, Pitot HC, et al. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogenic histocompatibility antigen HLA-B7. Gene Ther 1997;4:419-25
   PubMed Web of Science ®Google Scholar
• Hallaj-Nezhadi S, Lotfipour F, Dass C. Nanoparticle-mediated interleukin-12 cancer gene therapy. J Pharm Pharm Sci 2010;13:472-85
   PubMed Web of Science ®Google Scholar
• Rodrigo-Garzón M, Berraondo P, Ochoa L, et al. Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis. Cancer Gene Ther 2010;17:20-7
   PubMed Web of Science ®Google Scholar
• Ndoye A, Dolivet G, Hogset A, et al. Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization. Mol Ther 2006;13:1156-62
   PubMed Web of Science ®Google Scholar
• Wang M, Thanou M. Targeting nanoparticles to cancer. Pharm Res 2010;62:90-9
   Web of Science ®Google Scholar
• Mei M, Ren Y, Zhou X, et al. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Tech Cancer Res 2010;9:77-86
   PubMed Web of Science ®Google Scholar
• Tros de Ilarduya C, Garcia L, Düzgüneş N. Liposomes and lipopolymeric carriers for gene delivery. J Microencapsul 2010;27:602-8
   PubMed Web of Science ®Google Scholar
• Kircheis R, Ostermann E, Wolschek MF, et al. Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity. Cancer Gene Ther 2002;9:673-80
   PubMed Web of Science ®Google Scholar
• Ogris M, Walker G, Blesing T, et al. Tumor-targeted gene therapy. Strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release 2003;91:173-81
   PubMed Web of Science ®Google Scholar
• Sakaguchi N, Kojima C, Harada A, et al. Effect of transferrin as a ligand of pH-sensitive fusogenic liposome-lipoplex hybrid complexes. Bioconjug Chem 2008;19:1588-95
   PubMed Web of Science ®Google Scholar
• Abela RA, Qian J, Xu L, et al. Radiation improves gene delivery by a novel transferrin-lipoplex nanoparticle selectively in cancer cells. Cancer Gene Ther 2008;15:496-507
   PubMed Web of Science ®Google Scholar
• Sing M, Atwall H, Micetich R, et al. Transferrin directed delivery of adriamycin to human cells. Anticancer Res 1998;18:1423-7
   PubMed Web of Science ®Google Scholar
• Kratz F, Beyer U, Roth T, et al. Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy. J Pharm Sci 1998;87:338-46
   PubMed Web of Science ®Google Scholar
• Elliott RL, Stjernholm R, Elliott MC. Preliminary evaluation of platinum transferrin (MPTC-63) as a potential nontoxic treatment for breast cancer. Cancer Detect Prev 1998;12:469-80
   Google Scholar
• Beyer U, Roth T, Shumacher P, et al. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil. J Med Chem 1998;41:2701-8
   PubMed Web of Science ®Google Scholar
• Tanaka T, Shiramoto S, Miyashita M, et al. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). Int J Pharm 2004;277:39-61
   PubMed Web of Science ®Google Scholar
• Bejaoui N, Page M, Noel C. Cytotoxicity of transferrin-daunorubicin conjugates on small cell carcinoma of the lung (SCCL) cell line NCl-H69. Anticancer Res 1991;11:2211-13
   PubMed Web of Science ®Google Scholar
• Mayers GL, Raghavan D, Hitt S, et al. Transferrin-gemcitabine conjugate: application to chemotherapy. Proc Am Assoc Cancer Res 1998;89:63
   Google Scholar
• Ishida O, Marayuma K, Tanahashi H, et al. Liposomes bearing polyethyleneglycol-coupled transferrin with intra-cellular targeting property to the solid tumors in vivo. Pharm Res 2001;18:1042-8
   PubMed Web of Science ®Google Scholar
• Li X, Ding L, Xu Y, et al. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm 2009;373:116-23
   PubMed Web of Science ®Google Scholar
• Iinuma H, Maruyama K, Okinaga K, et al. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int J Cancer 2002;99:130-7
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Ma W, Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer 2004;112:335-40
   PubMed Web of Science ®Google Scholar
• Xu L, Frederik P, Pirollo KF, et al. Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery. Hum Gene Ther 2002;13:469-81
   PubMed Web of Science ®Google Scholar
• Xu L, Pirollo KF, Tang WH, et al. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther 1999;10:2941-52
   PubMed Web of Science ®Google Scholar
• Xu L, Pirollo KF, Chang EH. Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Hum Gene Ther 1997;8:467-75
   PubMed Web of Science ®Google Scholar
• Seki M, Iwakawa J, Cheng H, et al. p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy. Hum Gene Ther 2002;6:761-3
   Web of Science ®Google Scholar
• Xu L, Tang WH, Huang CC, et al. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol Med 2001;7:723-34
   PubMed Web of Science ®Google Scholar
• Xu L, Huang CC, Huang W, et al. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol Cancer Ther 2002;1:337-46
   PubMed Web of Science ®Google Scholar
• Camp ER, Wang C, Little EC, et al. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther 2013;20:222-8
   PubMed Web of Science ®Google Scholar
• Yu W, Pirollo KF, Rait A, et al. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Ther 2004;1:1434-40
   Web of Science ®Google Scholar
• Mendonça LS, Firmino F, Moreira JN, et al. Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment. Bioconjug Chem 2010;21:157-68
   PubMed Web of Science ®Google Scholar
• Davis ME, Zuckerman JE, Choi CH, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010;464:1067-70
   PubMed Web of Science ®Google Scholar
• Cardoso AL, Simões S, de Almeida LP, et al. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. J Gene Med 2007;9:170-83
   PubMed Web of Science ®Google Scholar
• Cardoso AL, Simões S, de Almeida LP, et al. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS. J Control Release 2008;2:113-23
   Web of Science ®Google Scholar
• Cardoso A, Trabulo S, Moreira JN, et al. Targeted lipoplexes for siRNA delivery. Methods Enzymol 2009;465:267-87
   PubMed Web of Science ®Google Scholar
• Cardoso AL, Costa P, de Almeida LP, et al. Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo. J Control Release 2010;142:392-403
   PubMed Web of Science ®Google Scholar
• Tros de Ilarduya C, Buñuales M, Qiang C, et al. Antitumoral activity of transferrin-lipoplexes carrying the IL-12 gene in the treatment of colon cancer. J Drug Target 2006;14:527-35
   PubMed Web of Science ®Google Scholar
• Jin Y, Liu S, Yu B, et al. Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia. Mol Pharm 2010;7:196-206
   PubMed Web of Science ®Google Scholar
• Ko YT, Bhattacharya R, Bickel U. Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting. J Control Release 2009;133:203-7
   Google Scholar
• Chiu SJ, Liu S, Perrotti D, et al. Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes. J Control Release 2006;112:199-207
   PubMed Web of Science ®Google Scholar
• Zhang X, Koh CG, Yu B, et al. Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide G3139 in a murine K562 xenograft model. Pharm Res 2009;26:1516-24
   PubMed Web of Science ®Google Scholar
• Neves SS, Sarmento-Ribeiro AB, Simoes SP, et al. Transfection of oral cancer cells mediated by transferrin-associated lipoplexes: mechanisms of cell death induced by herpes simplex virus thymidine kinase/ganciclovir therapy. Biochim Biophys Acta 2006;11:1703-12
   Web of Science ®Google Scholar
• Neves S, Faneca H, Bertin S, et al. Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response. Cancer Gene Ther 2009;16:91-101
   PubMed Web of Science ®Google Scholar
• da Cruz MT, Cardoso AL, de Almeida LP, et al. Tf-lipoplex-mediated NGF gene transfer to the CNS:neuronal protection and recovery in an excitotoxic model of brain injury. Gene Ther 2005;16:1242-52
   Web of Science ®Google Scholar
• Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 1999;31:1111-37
   PubMed Web of Science ®Google Scholar
• Yamada Y, Akita H, Harashima H. Multifunctional envelope-type nano device (MEND) for organelle targeting via a stepwise membrane fusion process. Methods Enzymol 2012;509:301-26
   PubMed Web of Science ®Google Scholar
• Düzgüneş N. A new paradigm for NIH grants. The Scientist 2007;21:24
   Google Scholar